Cargando…
Essential medicines for reproductive health: developing evidence based interagency list
Objectives: Although poor reproductive health constitutes a significant proportion of the disease burden in developing countries, essential medicines for reproductive health are often not available to the population. The objective was to analyze the guiding principles for developing national Essenti...
Autores principales: | Logez, Sophie, Jayasekar, Shalini, Moller, Helene, Ahmed, Kabir, Patel, Margaret Usher |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dr. Zaheer-Ud-Din Babar
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3471179/ https://www.ncbi.nlm.nih.gov/pubmed/23093884 http://dx.doi.org/10.5655/smr.v4i2.1003 |
Ejemplares similares
-
Interagency regulatory liaison group workshop on reproductive toxicity risk assessment.
por: Kimmel, C A, et al.
Publicado: (1986) -
An Interagency Collaboration to Facilitate Development of Filovirus Medical Countermeasures
por: Kilgore, Nicole, et al.
Publicado: (2012) -
Strengthening Health Surveillance through the Development of Interagency Relationships
por: Glidden, Emily V., et al.
Publicado: (2019) -
A comparative analysis of the Libyan national essential medicines list and the WHO model list of essential medicines
por: Mustafa, Asma Abubakr, et al.
Publicado: (2010) -
Interagency Regulatory Liaison Group role in phthalates.
por: Johns, P A
Publicado: (1982)